About Delexcel Pharma Private Limited
Data last updated:
Delexcel Pharma Private Limited is a private limited company based in Medak, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 04 September 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC095535. Its GSTIN is 36AAFCD1196C1ZW (Telangana).
The company has an authorised share capital of ₹16 Cr and a paid-up capital of ₹10 Cr. It is led by directors including Madhava Rao Tumati and Venkata Sirisha Tumati.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Medak, Telangana.
As per the financials filed for FY 2022, the company reported a revenue of ₹7.13 Cr, a decline of 33% compared to the previous year. For the same year it recorded a net loss of ₹3.85 Cr (net margin -54%) and EBITDA of ₹1.08 Cr (EBITDA margin 15.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 205% over five years.
The company has about 67 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹25 Cr on record. Court records list 5 cases involving the company, including 3 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website delexcelpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressSurvey No 228/2& 228/3 Kucharam Village Beside Tsiic Manoharaba, D Mandal, Medak, Telangana, India – 502336
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Delexcel Pharma Private Limited
The main business activity of Delexcel Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Delexcel Pharma Private Limited FY 2022 filings available
Delexcel Pharma Private Limited reported revenue of ₹7.13 Cr (down 33% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Delexcel Pharma Private Limited
Revenue fell 33% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 205%. EBITDA fell 77% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Delexcel Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.08 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.85 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Delexcel Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -54% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Delexcel Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Delexcel Pharma Private Limited
Delexcel Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kaisha Lifesciences Private Limited | ₹7.16 Cr (FY 2025) | •••• | •••• | 2052.0% | •••• | Mumbai, Maharashtra, India |
| PRS Pharmaceuticals Private Limited | ₹7.16 Cr (FY 2019) | •••• | •••• | 40.0% | •••• | Salem, Tamil Nadu, India |
| Solace Biotech Limited | ₹7.14 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Saha, Haryana, India |
| Healthnovo Pharmaceutical Private Limited | ₹7.14 Cr (FY 2025) | •••• | •••• | 337.0% | •••• | Mumbai, Maharashtra, India |
| Chereso Life Sciences Private Limited | ₹7.13 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Derrabassi, Punjab, India |
| Delexcel Pharma Private Limited this company | ₹7.13 Cr (FY 2022) | •••• | •••• | -33.0% | •••• | Medak, Telangana, India |
| Worth Medicines India Private Limited | ₹7.12 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Himachal Pradesh, India |
| Priority Pharmaceuticals Private Limited | ₹7.12 Cr (FY 2025) | •••• | •••• | 174.0% | •••• | Jaipur, Rajasthan, India |
| Beynon Pharma Private Limited | ₹7.11 Cr (FY 2020) | •••• | •••• | 285.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Promenade Lifecare Private Limited | ₹7.11 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Delhi, India |
| Baravkar Health Science (BHS) Pharmaceuticals Private Limited | ₹7.11 Cr (FY 2025) | •••• | •••• | •••• | Pune, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Delexcel Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Delexcel Pharma Private Limited
Delexcel Pharma Private Limited is audited by B SRINIVASA RAO & CO for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B SRINIVASA RAO & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Delexcel Pharma Private Limited
Delexcel Pharma Private Limited currently reports 4 directors and 1 key managerial person.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madhava Rao Tumati Also directs: Deccan Abode Private Limited, TMR Developers Private Limited | Director | 04 Sep 2014 | 12 Years 1 Months | Current |
| Venkata Sirisha Tumati Also directs: TMR Developers Private Limited | Director | 04 Sep 2014 | 12 Years 1 Months | Current |
| Raghupathi Kandarapu | Ceo | 06 Jun 2016 | 10 Years 4 Months | Current |
| Rahul Prabhakar Vaidya Also directs: Dunamas Pharmaceuticals Association | Director | 18 Dec 2025 | 0 Years 9 Months | Current |
| Tumati Lakshmi Deepak Also directs: TMR Developers Private Limited | Director | 11 Feb 2026 | 0 Years 7 Months | Current |
Ownership and Shareholding of Delexcel Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Delexcel Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Feb 2017 | Others | ₹25 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Delexcel Pharma Private Limited
Delexcel Pharma Private Limited has 5 court cases on record: 3 filed against it, 2 where it is another party. 2 cases are pending and 3 are disposed. Status as checked between 28 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 2 | 1 |
| District courts | 1 | 1 | 1 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| High Court of Delhi | Arbitration matter | Filed against the company by Morepen Laboratories Limited | Disposed |
| High Court for State of Telangana | Writ petition | Filed against the company by an individual | Pending |
| High Court for State of Telangana | Court case (CRLP) | Company is another party | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Delexcel Pharma Private Limited
Delexcel Pharma Private Limited has a workforce of 67 employees as of Apr 05, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Delexcel Pharma Private Limited
Delexcel Pharma Private Limited has 5 board changes on record since 2014: 5 appointments. The latest: Tumati Lakshmi Deepak was appointed as Director on 11 Feb 2026.
Credit Ratings, Litigation & Regulatory Alerts for Delexcel Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Delexcel Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Delexcel Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Delexcel Pharma Private Limited
Delexcel Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCD1196C1ZW | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Delexcel Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Delexcel Pharma Private Limited
Delexcel Pharma is an active private limited company based in Medak, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 04 September 2014 (12+ years old) and is registered under CIN U24232TG2014PTC095535.
Delexcel Pharma reported revenue of ₹7.13 Cr for FY 2022 (down 33% YoY).
Delexcel Pharma has 5 current directors and KMP:
- Madhava Rao Tumati - Director
- Venkata Sirisha Tumati - Director
- Rahul Prabhakar Vaidya - Director
- Tumati Lakshmi Deepak - Director
- Raghupathi Kandarapu - Ceo
Delexcel Pharma reported a net loss of ₹3.85 Cr (net margin -54%) and EBITDA of ₹1.08 Cr (EBITDA margin 15.2%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Delexcel Pharma is 2% over three years and 205% over five years. In the latest year (FY 2022) revenue fell 33%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Delexcel Pharma is 36AAFCD1196C1ZW, registered in Telangana.
The CIN (Corporate Identification Number) of Delexcel Pharma is U24232TG2014PTC095535. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Delexcel Pharma has 5 court cases on record: 3 filed against it. 2 are pending. Most are in the high courts.
Delexcel Pharma was incorporated on 04 September 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Delexcel Pharma by revenue are Kaisha Lifesciences Private Limited, PRS Pharmaceuticals Private Limited, Solace Biotech Limited, Healthnovo Pharmaceutical Private Limited, Chereso Life Sciences Private Limited and 5 more, all in the Pharma industry (Formulations).
Tumati Lakshmi Deepak was appointed as Director on 11 Feb 2026. Rahul Prabhakar Vaidya was appointed as Director on 18 Dec 2025. Raghupathi Kandarapu was appointed as CEO on 06 Jun 2016. Delexcel Pharma has 5 board changes on record in total.